BRPI0716320A2 - Método para reduzir a absorção de fosfato em um individuo animal humano e não- humano e método para reduzir a absorção de fosfato em um individuo humano - Google Patents

Método para reduzir a absorção de fosfato em um individuo animal humano e não- humano e método para reduzir a absorção de fosfato em um individuo humano

Info

Publication number: BRPI0716320A2
Authority: BR; Brazil
Prior art keywords: human; individual; phosphate absorption; reducing phosphate; reducing
Prior art date: 2006-10-26

Application number

BRPI0716320-7A2A

Other languages

English (en)

Inventor

Mark Cook

Martin Petrovich

Erica Hellestad

Original Assignee

Wisconsin Alumni Res Found

Aovatechnologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-26

Filing date

2007-10-23

Publication date

2014-02-25

2007-10-23 Application filed by Wisconsin Alumni Res Found, Aovatechnologies Inc filed Critical Wisconsin Alumni Res Found

2014-02-25 Publication of BRPI0716320A2 publication Critical patent/BRPI0716320A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Biochemistry (AREA)
Immunology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

BRPI0716320-7A2A 2006-10-26 2007-10-23 Método para reduzir a absorção de fosfato em um individuo animal humano e não- humano e método para reduzir a absorção de fosfato em um individuo humano BRPI0716320A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US85455006P	2006-10-26	2006-10-26
PCT/US2007/082236 WO2008067084A2 (en)	2006-10-26	2007-10-23	Methods for reducing phosphate absorption

Publications (1)

Publication Number	Publication Date
BRPI0716320A2 true BRPI0716320A2 (pt)	2014-02-25

Family

ID=38983491

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BRPI0716320-7A2A BRPI0716320A2 (pt)	2006-10-26	2007-10-23	Método para reduzir a absorção de fosfato em um individuo animal humano e não- humano e método para reduzir a absorção de fosfato em um individuo humano
BRPI0716317A BRPI0716317A8 (pt)	2006-10-26	2007-10-23	método para reduzir a absorção de fosfato em um indivíduo animal humano ou não-humano e método para reduzir a absorção de fosfato em um indivíduo humano

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
BRPI0716317A BRPI0716317A8 (pt)	2006-10-26	2007-10-23	método para reduzir a absorção de fosfato em um indivíduo animal humano ou não-humano e método para reduzir a absorção de fosfato em um indivíduo humano

Country Status (8)

Country	Link
US (2)	US8877198B2 (pt)
EP (2)	EP2076543B1 (pt)
JP (3)	JP2010508281A (pt)
CN (2)	CN101595131A (pt)
AU (2)	AU2007325459A1 (pt)
BR (2)	BRPI0716320A2 (pt)
CA (2)	CA2667563A1 (pt)
WO (2)	WO2008067084A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8802094B2 (en)	2006-10-25	2014-08-12	Wisconsin Alumni Research Foundation	Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody
BRPI0716320A2 (pt) *	2006-10-26	2014-02-25	Wisconsin Alumni Res Found	Método para reduzir a absorção de fosfato em um individuo animal humano e não- humano e método para reduzir a absorção de fosfato em um individuo humano
EP2334292B1 (en) *	2008-10-17	2019-05-08	Fresenius Medical Care Holdings, Inc.	Method of determining a phosphorus binder dosage for a dialysis patient
EP3556398A1 (en) *	2018-04-16	2019-10-23	Croda Denmark A/S	Phytates for use as a biomolecules delivery or adsorption system
CA3109804A1 (en)	2018-08-16	2020-02-20	The Regents Of The University Of California	Chemically and photochemically initiated cell membrane blebbing to induce cell vesicle production, modifications thereof, and uses thereof
WO2024233943A2 (en) *	2023-05-10	2024-11-14	Chosen Diagnostics Inc.	Alkaline phosphatase antibodies and uses thereof
US12150954B1 (en) *	2023-11-21	2024-11-26	Protekta Inc.	Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals
US12310984B1 (en) *	2023-11-21	2025-05-27	Protekta Inc.	Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2052496T3 (es) *	1985-11-25	1994-07-16	Ghen Corp	Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso.
US5496545A (en)	1993-08-11	1996-03-05	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
AU1526995A (en)	1994-01-13	1995-08-01	Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations, The	Antibodies specific for d-myo-inositol 1,4,5-trisphosphate
ATE238810T1 (de) *	1994-08-05	2003-05-15	Wisconsin Alumni Res Found	Cck-antikörper zur verbesserung der futterverwertung
EP0793960B1 (en)	1996-03-05	2001-08-01	Mitsubishi Chemical Corporation	Use of anion exchange resins for the manufacture of a medicament for the treatment of hyperphosphatemia
CN1230118A (zh) *	1996-07-19	1999-09-29	日研化学株式会社	高磷血症治疗剂
US6423754B1 (en)	1997-06-18	2002-07-23	Geltex Pharmaceuticals, Inc.	Method for treating hypercholesterolemia with polyallylamine polymers
US5985938A (en) *	1997-11-05	1999-11-16	Geltex Pharmaceuticals, Inc.	Method for reducing oxalate
CH694588A5 (de) *	1999-02-09	2005-04-15	Hoffmann La Roche	Menschliche intestinale Npt2B.
US6213930B1 (en)	1999-03-15	2001-04-10	Wisconsin Alumni Research Foundation	Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency
US6346247B1 (en) *	1999-10-28	2002-02-12	Promega Corporation	Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
CA2395840A1 (en) *	1999-12-27	2001-07-05	The University Of Manitoba	Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens
WO2002003788A2 (en) *	2000-07-06	2002-01-17	Deltagen, Inc.	Transgenic mice containing targeted phosphatase gene disruptions
US7883703B2 (en) *	2003-11-14	2011-02-08	The Brigham And Women's Hospital, Inc.	Methods of modulating immunity
JP4886983B2 (ja) *	2004-12-09	2012-02-29	アサマ化成株式会社	抗体を含有する機能性組成物
US8802094B2 (en)	2006-10-25	2014-08-12	Wisconsin Alumni Research Foundation	Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody
BRPI0716320A2 (pt) *	2006-10-26	2014-02-25	Wisconsin Alumni Res Found	Método para reduzir a absorção de fosfato em um individuo animal humano e não- humano e método para reduzir a absorção de fosfato em um individuo humano

2007
- 2007-10-23 BR BRPI0716320-7A2A patent/BRPI0716320A2/pt not_active IP Right Cessation
- 2007-10-23 CA CA002667563A patent/CA2667563A1/en not_active Abandoned
- 2007-10-23 CA CA002667613A patent/CA2667613A1/en not_active Abandoned
- 2007-10-23 AU AU2007325459A patent/AU2007325459A1/en not_active Abandoned
- 2007-10-23 JP JP2009534815A patent/JP2010508281A/ja active Pending
- 2007-10-23 AU AU2007309026A patent/AU2007309026B2/en not_active Ceased
- 2007-10-23 US US12/447,338 patent/US8877198B2/en active Active
- 2007-10-23 WO PCT/US2007/082236 patent/WO2008067084A2/en not_active Ceased
- 2007-10-23 JP JP2009534818A patent/JP5701504B2/ja not_active Expired - Fee Related
- 2007-10-23 US US12/447,193 patent/US20100143385A1/en not_active Abandoned
- 2007-10-23 CN CNA2007800481391A patent/CN101595131A/zh active Pending
- 2007-10-23 EP EP07844535.0A patent/EP2076543B1/en not_active Not-in-force
- 2007-10-23 WO PCT/US2007/082244 patent/WO2008051977A2/en not_active Ceased
- 2007-10-23 EP EP07871216A patent/EP2081963A2/en not_active Withdrawn
- 2007-10-23 BR BRPI0716317A patent/BRPI0716317A8/pt not_active Application Discontinuation
- 2007-10-23 CN CNA2007800482197A patent/CN101583627A/zh active Pending
2013
- 2013-04-11 JP JP2013083225A patent/JP2014237591A/ja active Pending

Also Published As

Publication number	Publication date
US20100143385A1 (en)	2010-06-10
JP2010508281A (ja)	2010-03-18
CN101595131A (zh)	2009-12-02
AU2007325459A1 (en)	2008-06-05
WO2008051977A8 (en)	2009-05-28
WO2008051977A3 (en)	2008-07-03
CA2667613A1 (en)	2008-06-05
US8877198B2 (en)	2014-11-04
AU2007309026B2 (en)	2013-09-12
EP2076543B1 (en)	2016-01-27
WO2008067084A3 (en)	2008-07-31
JP2010508282A (ja)	2010-03-18
JP5701504B2 (ja)	2015-04-15
BRPI0716317A8 (pt)	2019-02-05
WO2008067084A2 (en)	2008-06-05
US20100233184A1 (en)	2010-09-16
CN101583627A (zh)	2009-11-18
CA2667563A1 (en)	2008-05-02
BRPI0716317A2 (pt)	2014-02-25
WO2008051977A2 (en)	2008-05-02
AU2007309026A1 (en)	2008-05-02
EP2076543A2 (en)	2009-07-08
EP2081963A2 (en)	2009-07-29
JP2014237591A (ja)	2014-12-18

Legal Events

Date	Code	Title	Description
2014-08-26	B08L	Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]	Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 6A E 7A ANUIDADES.
2020-11-10	B08I	Publication cancelled [chapter 8.9 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.
2020-11-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.
2021-03-09	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0819075A2 (pt)	2014-10-07	Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
BRPI0914090A2 (pt)	2015-10-27	sistema de redução e método para reduzir um período de penalidade para um trem de potência distribuida
BRPI0716320A2 (pt)	2014-02-25	Método para reduzir a absorção de fosfato em um individuo animal humano e não- humano e método para reduzir a absorção de fosfato em um individuo humano
EP1800120A4 (en)	2012-04-18	METHODS AND SYSTEMS FOR PROVIDING AN INDIVIDUAL ANIMAL-SPECIFIC ALICAMENT PROGRAM
BRPI0722059A2 (pt)	2014-04-01	Método para incorporar matriz de silício existente dentro de pilha integrada de 3d
BRPI0908656A2 (pt)	2015-08-11	''método para reduzir a corrosão de sensor em artigos absorventes''
FI20085920A7 (fi)	2008-09-29	Menetelmä ja järjestelmä harjoitteleun ohjaamiseksi
BRPI0906683A2 (pt)	2017-08-22	método para medir e caracterizar microvesículas em fluidos corporais humanos
GB0801176D0 (en)	2008-02-27	Device and method for use in construction
DE602007011544D1 (de)	2011-02-10	Batterieverwaltungssystem und Antriebsverfahren
CL2007002965A1 (es)	2008-06-27	Metodo y sistema para entregar y ejecutar las mejores practicas en proyectos de desarrollo de yacimiento petrolifero.
FI20060387L (fi)	2007-10-22	Kyselyjen ja kutsujen SMS-jakelumenetelmä
GB2451561B (en)	2009-11-04	System and method for providing power in a well
BRPI0822095A2 (pt)	2014-10-07	Método para reduzir o sangramento e/ou hematoma em um paciente
BRPI0819642A2 (pt)	2015-05-26	Método para a formação de uma dentadura para um paciente em uma única visita, e, dentadura
BRPI0915698A2 (pt)	2016-02-10	método para medir o conteúdo de água em um composto e dispositivo de medição de conteúdo de água
BRPI0913342A2 (pt)	2016-08-16	métodos e aparelho para redução de potência em um transceptor
BRPI0918103A2 (pt)	2016-07-05	"método para o tratamento da dor em um indivíduo"
BRPI1006353A2 (pt)	2018-02-14	dispositivo e método para fazer almofadas absorventes usadas em itens de higiene pessoal.
IL194668A0 (en)	2011-08-01	System and method for creating microablated channels in skin
BRPI0815176A2 (pt)	2015-03-31	Método e sensor para perceber moedas para avaliação
BRPI0716397A2 (pt)	2013-09-17	mÉtodos para identificar agentes que promovem a osteogÊnese e para promover a osteogÊnese em uma cÉlula de mamÍfero.
BRPI0621937A2 (pt)	2016-09-20	suplemento alimentar baseado em licopeno biológico e processo de co-extração de licopeno biológico
BRPI0718035A2 (pt)	2014-06-24	Método e disposição para fabricação de metanol
BRPI0809341A2 (pt)	2014-10-07	Dispositivo e método para carga rápida de baterias